Gritstone Bio Inc (GRTS)
0.7826
+0.04
(+4.82%)
USD |
NASDAQ |
May 17, 16:00
0.7826
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Accounts Payable (Quarterly): 7.248M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.248M |
December 31, 2023 | 3.819M |
September 30, 2023 | 4.265M |
June 30, 2023 | 4.925M |
March 31, 2023 | 5.975M |
December 31, 2022 | 8.694M |
September 30, 2022 | 2.885M |
June 30, 2022 | 2.381M |
March 31, 2022 | 5.641M |
December 31, 2021 | 4.23M |
September 30, 2021 | 3.393M |
June 30, 2021 | 4.795M |
March 31, 2021 | 6.368M |
Date | Value |
---|---|
December 31, 2020 | 9.578M |
September 30, 2020 | 3.284M |
June 30, 2020 | 4.301M |
March 31, 2020 | 5.008M |
December 31, 2019 | 4.621M |
September 30, 2019 | 6.737M |
June 30, 2019 | 5.253M |
March 31, 2019 | 3.622M |
December 31, 2018 | 4.825M |
September 30, 2018 | 3.874M |
June 30, 2018 | 2.671M |
December 31, 2017 | 3.935M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.381M
Minimum
Jun 2022
9.578M
Maximum
Dec 2020
5.17M
Average
4.86M
Median
Accounts Payable (Quarterly) Benchmarks
Precision BioSciences Inc | 1.136M |
Humacyte Inc | 3.452M |
Verastem Inc | 7.449M |
BioVie Inc | -- |
Adial Pharmaceuticals Inc | 0.1033M |